Lataa...
Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery()
BACKGROUND: New vaccines to prevent tuberculosis are urgently needed. MVA85A is a novel viral vector TB vaccine candidate designed to boost BCG-induced immunity when delivered intradermally. To date, intramuscular delivery has not been evaluated. Skin and muscle have distinct anatomical and immunolo...
Tallennettuna:
| Julkaisussa: | Vaccine |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier Science
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5405058/ https://ncbi.nlm.nih.gov/pubmed/23266342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.12.042 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|